| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |